Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
stock ticker
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:acquisitionYear |
2014
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
orphan drugs
pulmonary diseases |
| gptkbp:headquarters |
gptkb:Brisbane,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
ITMN
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:pirfenidone
|
| gptkbp:refersTo |
InterMune, Inc.
|
| gptkbp:status |
acquired
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:InterMune
|
| gptkbp:bfsLayer |
8
|